Dow Up 0.11% Nasdaq Up 0.50%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
350.45 Up 3.53(1.02%) Aug 29, 4:00PM EDT
|After Hours : 350.42 Down 0.03 (0.01%) Aug 29, 6:35PM EDT
Prev Close:346.92
Open:349.10
Bid:350.45 x 500
Ask:352.75 x 300
1y Target Est:353.28
Beta:0.65
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:346.20 - 350.74
52wk Range:245.99 - 354.79
Volume:525,535
Avg Vol (3m):812,423
Market Cap:35.18B
P/E (ttm):100.47
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for REGN

Comparison

Symbol% ChgMkt Cap
REGNUp 1.02%35.18B
AMGNUp 0.50%105.87B
NVSUp 0.12%217.97B
RHHBYDown 0.14%248.08B

Key Statistics

Forward P/E (1 yr):28.61
P/S (ttm):13.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.15
Quarterly EPS Est (Sep-14) :2.58
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback